|
시장보고서
상품코드
2038937
CDMO 주사제 시장 : 제품 유형별, 약제 클래스별, 용도별, 투여 경로별, 사업 규모별, 최종사용자별, 지역별CDMO Injectable Drugs Market, By Product Type, By Drug Class, By Application, By Route of Administration, By Scale of Operations, By End User, By Geography |
||||||
CDMO 주사제 시장은 2026년에 186억 5,010만 달러로 추계되고 있으며, 2033년까지 328억 1,990만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 8.4%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 186억 5,010만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 8.40% | 2033년 시장 규모 예측 : | 328억 1,990만 달러 |
세계의 CDMO 주사제 시장은 제약 산업에서 중요한 부문 중 하나이며, 무균 주사제 관련 위탁 개발 및 제조(CDMO) 활동에 종사하는 조직으로 구성되어 있습니다. 이러한 기업은 특수 장비, 전문 지식, 첨단 품질관리가 필요한 복잡한 제조 공정과 관련된 아웃소싱 서비스를 제공하는 필수적인 공급업체가 되었습니다. 주사제(정맥주사, 근육주사, 피하주사)는 신중한 치료가 필요하므로 제약업계에서 CDMO의 참여는 필수적입니다.
분석 대상 시장에는 종양학, 면역학, 심혈관 질환, 중추신경계(CNS) 질환, 바이오의약품 및 바이오시밀러 등 몇 가지 주요 부문이 있습니다. CDMO는 특정 분야에 특화되어 있으므로 다양한 유형의 의약품 제조에 있으며, 매우 효과적인 파트너가 될 수 있습니다. 오늘날 CDMO의 활동을 통해 제약기업은 기존 의약품 생산이 아닌 신제품 개발에 집중할 수 있으므로 CDMO의 활용이 점점 더 널리 보급되고 있습니다.
시장 역학
세계의 CDMO 주사제 시장은 주사제, 특히 특수한 제조 공정을 필요로 하는 바이오시밀러의 개발에 따른 복잡성 증가로 인해 주도되고 있습니다. 의료비 증가와 더불어 고령화 및 각종 만성질환의 확산으로 인해 다양한 주사제에 대한 수요가 증가하고 있습니다. 다수의 블록버스터 의약품의 특허가 만료됨에 따라 바이오시밀러 개발에 대한 관심이 높아지고 있으며, 이는 주사제 시장 부문에서 CDMO의 중요성을 더욱 높이고 있습니다.
그러나 업계에는 몇 가지 해결해야 할 과제도 존재하며, 그 중에는 GMP(Good Manufacturing Practice)와 같은 규제를 엄격하게 준수해야 하는 문제도 있습니다. 이러한 규제를 충족하기 위해서는 철저한 품질관리와 공장 개보수를 위한 막대한 설비투자가 필요합니다. 무균 제조 시설을 구축하는 데 필요한 자본 비용은 상대적으로 높은 임베디드니다. 또한 전 세계 생산 네트워크는 공급망의 혼란에 취약한 것으로 밝혀졌습니다. 그럼에도 불구하고 의료 인프라가 구축되고 있는 개발도상국에서는 새로운 기회가 생겨나고 있습니다. 또한 맞춤형 의료와 새로운 약물전달 시스템에 대한 전문화는 CDMO에게 타사와의 차별화를 통해 하이엔드 제조 계약을 획득할 수 있는 기회를 가져다주고 있습니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 이 보고서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 연구는 다음과 같은 매개 변수를 기반으로 세계의 CDMO 주사제 시장의 주요 기업 개요을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 CDMO 주사제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 CDMO 주사제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 CDMO 주사제 시장 : 제품 유형별, 2021-2033년
제5장 세계의 CDMO 주사제 시장 : 약제 클래스별, 2021-2033년
제6장 세계의 CDMO 주사제 시장 : 용도별, 2021-2033년
제7장 세계의 CDMO 주사제 시장 : 투여 경로별, 2021-2033년
제8장 세계의 CDMO 주사제 시장 : 사업 규모별, 2021-2033년
제9장 세계의 CDMO 주사제 시장 : 최종사용자별, 2021-2033년
제10장 세계의 CDMO 주사제 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 추천
제13장 참고 문헌 및 조사 방법
KSA 26.06.02CDMO Injectable Drugs Market is estimated to be valued at USD 18,650.1 Mn in 2026 and is expected to reach USD 32,819.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 18,650.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.40% | 2033 Value Projection: | USD 32,819.9 Mn |
Global CDMO injectable drugs market represents one of the important segments within the pharmaceutical industry and is formed by organizations that are engaged in contract development and manufacturing activities related to sterile injectables. Such firms have become indispensable suppliers of outsourced services related to the complex process of manufacturing that requires special equipment, knowledge, and high-quality control. Injectable products (IV, IM, and SC injections) require careful treatment, and this makes involvement of CDMOs a necessity for the pharmaceutical industry.
There are several important segments of the analyzed market such as oncology, immunology, cardiovascular diseases, CNS disorders, as well as biologics and biosimilars. Due to specialization in particular areas, CDMOs can become very effective partners in manufacturing of various types of pharmaceutical products. Nowadays, CDMOs are becoming increasingly popular among pharmaceutical companies since their activities allow for concentrating efforts on developing new products rather than manufacturing existing drugs.
Market Dynamics
The global CDMO injectable drugs market is propelled by the increased complexity involved in the development of injectables and especially biosimilars, which have specialized manufacturing processes. Increasing healthcare spending, coupled with the growth in elderly populations and prevalence of various chronic diseases, is increasing the demand for various injectable medicines. The patents of various blockbusters have expired, leading to an increased focus on developing biosimilars, which is fueling the importance of CDMOs in injectable market segments.
However, there are some challenges that should be addressed in the industry, among which include strict compliance with regulations such as GMP (good manufacturing practice). Meeting these regulations requires significant capital investment for the purpose of attaining quality control and upgrading the plant. The capital cost required to establish a sterile production facility is relatively high. Moreover, global production networks have been found vulnerable to supply chain disruptions. Nonetheless, opportunities are arising in developing countries where health care infrastructure is improving. Additionally, specialization in personalized medicines and novel drug delivery systems presents CDMOs with chances to differentiate themselves and secure high-end manufacturing contracts.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global CDMO injectable drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Lonza Group, Thermo Fisher Scientific, Catalent, Inc., Samsung Biologics, WuXi Biologics, FUJIFILM Diosynth Biotechnologies, Boehringer Ingelheim, Recipharm AB, Siegfried Holding AG, and AGC Biologics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global CDMO injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global CDMO injectable drugs market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Small Molecule Injectables
- Large Molecule Injectables
- Drug Class Insights (Revenue, USD Mn, 2021 - 2033)
- Antidiabetics
- Cardiovascular Drugs
- Anti-infectives
- Analgesics and Anesthetics
- Oncology Drugs
- Vaccines
- CNS Drugs
- Hormonal Drugs
- Others
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Diabetes
- Autoimmune Diseases
- Hematological Disorders
- Cardiovascular Diseases
- Infectious Diseases
- Neurological Disorders
- Pain Management
- Rare Diseases
- Others
- Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Intramuscular (IM)
- Intravenous (IV)
- Subcutaneous (SC)
- Others
- Scale of Operations Insights (Revenue, USD Mn, 2021 - 2033)
- Preclinical Development
- Clinical Development (Phases I-III)
- Commercial / Large-Scale Manufacturing
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Biopharmaceutical Companies
- Generic Drug Manufacturers
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Lonza Group
- Thermo Fisher Scientific
- Catalent, Inc.
- Samsung Biologics
- WuXi Biologics
- FUJIFILM Diosynth Biotechnologies
- Boehringer Ingelheim
- Recipharm AB
- Siegfried Holding AG
- AGC Biologics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global CDMO Injectable Drugs Market, By Product Type
- Global CDMO Injectable Drugs Market, By Drug Class
- Global CDMO Injectable Drugs Market, By Application
- Global CDMO Injectable Drugs Market, By Route of Administration
- Global CDMO Injectable Drugs Market, By Scale of Operations
- Global CDMO Injectable Drugs Market, By End User
- Global CDMO Injectable Drugs Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global CDMO Injectable Drugs Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Small Molecule Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Large Molecule Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global CDMO Injectable Drugs Market, By Drug Class, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Antidiabetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cardiovascular Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Anti-infectives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Analgesics and Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oncology Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- CNS Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hormonal Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global CDMO Injectable Drugs Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Hematological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Rare Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global CDMO Injectable Drugs Market, By Route of Administration, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Intramuscular (IM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Subcutaneous (SC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global CDMO Injectable Drugs Market, By Scale of Operations, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Preclinical Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Clinical Development (Phases I-III)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Commercial / Large-Scale Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global CDMO Injectable Drugs Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Generic Drug Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global CDMO Injectable Drugs Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Catalent, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Samsung Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FUJIFILM Diosynth Biotechnologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Recipharm AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siegfried Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AGC Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
